Journal of Clinical Virology

Papers
(The TQCC of Journal of Clinical Virology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Quantification of human immunodeficiency virus type 2 (HIV-2) viral load in plasma: Comparison of three commercial assays74
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization68
Multicenter performance evaluation of the Elecsys HCV Duo immunoassay56
Trends in the detection of viruses causing gastroenteritis over a 10-year period and impact of nonpharmaceutical interventions50
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens46
ESCV/PASCV Membership44
Persistence of G10P[11] neonatal rotavirus infections in southern India43
Corrigendum to “First international proficiency study on human papillomavirus testing in cervical cancer screening” [J Clin Virol. 2023 Oct;167:105581]41
Corrigendum to “Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus” Journal of Clinical Virology 45 (39
Comparison of two assays to diagnose herpes simplex virus in patients with central nervous system infections39
Enrichment of SARS-CoV-2 sequence from nasopharyngeal swabs whilst identifying the nasal microbiome38
Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain38
Comparison of sputum specimens and nasopharyngeal swab specimens for diagnosis of acute human metapneumovirus-related lower respiratory tract infections in adults38
Editorial Board32
Epidemiology of hand, foot and mouth disease and genomic surveillance of coxsackievirus A10 circulating in Zhejiang Province, China during 2017 to 202232
The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays31
Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population31
Evaluation of a next generation sequencing assay for Hepatitis B antiviral drug resistance on the oxford nanopore system31
Retrospective identification of congenital cytomegalovirus infection using dried blood samples - missed opportunities and lessons30
Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.29
Recent HIV-1 infection in Israel 2017–2021: Evaluation of geenius and HIV-1/2 combo assays for identifying recent infection detected by Sedia assay and assessment of factors related to recent infectio28
Editorial Board28
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use26
Performance of the Xpert™ Mpox PCR assay with oropharyngeal, anorectal, and cutaneous lesion swab specimens25
Development of real-time RT-PCR assays to detect measles virus on the Hologic Panther Fusion® System25
Editorial Board24
A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children <2 years of age in the U.S.24
Highly sensitive and specific detection of the SARS-CoV-2 Delta variant by double-mismatch allele-specific real time reverse transcription PCR24
Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)—A prospective multicenter study23
Clinical presentation, viral shedding, and neutralizing antibody responses of mpox cases in South Korea: Single center experience23
Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.22
Human coronaviruses: Origin, host and receptor22
Multicenter benchmarking of short and long read wet lab protocols for clinical viral metagenomics22
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations21
Direct whole-genome sequencing of HIV-1 for clinical drug-resistance analysis and public health surveillance21
Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia21
The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.21
Optimising nucleic acid recovery from rapid antigen tests for whole genome sequencing of respiratory viruses21
Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study21
Application of the ViroKey® SQ FLEX assay for detection of cytomegalovirus antiviral resistance20
Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection20
Opt-out HIV screening in adults attending the Emergency Department of a London teaching hospital20
Predictors of chronic joint pain after Chikungunya virus infection in the INOVACHIK prospective cohort study19
Comparison of humoral immunogenicity in solid organ transplant recipients after third-dose mRNA vaccine with homologous or heterologous schedules: An observational study19
Non-polio enterovirus aseptic meningitis in infants up to three months of age, the bacterial mask of viral disease: A retrospective cohort study19
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis18
Influence of preanalytical parameters on influenza and respiratory syncytial virus molecular detection18
Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong18
Comparison of analytical sensitivity of the eight rapid antigen detection kits for detecting SARS-CoV-2 virus18
ESCV/PASCV Membership18
The molecular epidemiology of respiratory syncytial virus in Ontario, Canada from 2022–2024 using a custom whole genome sequencing assay and analytics package18
Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome17
Editorial Board17
Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study17
A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field16
Current regulatory landscape for viral point-of-care testing in the United States16
Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities16
Accurate quantification using the new RoboGene HDV RNA Quantification Kit 3.0: A European multicenter study16
Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response16
Prevalence and persistence of HPV-16 molecular variants in the anal canal of men: The HIM study16
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settings16
Investigation of suspected false positive norovirus results on a syndromic gastrointestinal multiplex molecular panel15
Comparison of nucleocapsid antigen with strand-specific reverse-transcription PCR for monitoring SARS-CoV-2 infection15
Detection of early phase human T-cell leukemia virus type 1 and 2 infection with an improved confirmatory test15
Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures15
Characteristics of hepatitis E viral infections in Hungary15
Clinical utility of SARS-CoV-2 subgenomic RT-PCR in a pediatric quaternary care setting15
False-positive results in fourth-generation HIV screening tests: Prevalence and associated factors in Sichuan, a high HIV burden province of China14
Circulating serotypes and genotypes of dengue virus during the 2023 outbreak in Eastern Nepal14
Parvovirus B19 remains an underestimated pathogen among infections during gestation in Argentina: Insights through the study of symptomatic and asymptomatic pregnant patients and newborns from Córdoba14
DENV-1 genotype V linked to the 2022 dengue epidemic in Southern Brazil14
HIV-1 genotypic resistance testing using single molecule real-time sequencing14
Detection of intrathecal antibodies to diagnose enterovirus infections of the central nervous system14
A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses13
Childhood encephalitis hospitalizations associated with virus agents in medium-endemic states in India13
In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing13
Editorial Board13
The evolving landscape of Norovirus GII genotypes in Asia: A systematic review and meta-analysis13
Evaluation of four laboratory-based high-throughput SARS-CoV-2 automated antigen tests compared to RT-PCR on nasal and oropharyngeal samples13
Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment13
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study13
Clinical evaluation of Xpert HIV Qual XC assay in diverse HIV-1 subtypes circulating in China13
Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects13
Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus12
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients12
Clinical characterization of COVID-19 breakthrough infections, Philippines12
Arbovirus outbreak in a rural region of the Brazilian Amazon12
Evaluation of urinary hepatitis E virus antigen colloidal gold immunochromatographic assay in clinical diagnosis of hepatitis E virus infection12
Genotypic shift in rotavirus associated with neonatal outbreaks in Seoul, Korea12
Heterogeneity of false reactivity profiles of HIV assays while optimizing national HIV testing algorithms: Findings from a multi-country analysis12
Genotypic testing improves detection of antiviral resistance in human herpes simplex virus12
Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals12
A Prospective Study of Plasma and Bronchoalveolar Lavage Fluid CMV DNA Load Quantification for the Diagnosis and Outcome of CMV Pneumonitis in Immunocompromised Hosts12
Diagnosing congenital cytomegalovirus infections using archived dried blood spots: A 15-year observational study, Portugal12
Impact on hospital length of stay and antimicrobial usage in children diagnosed with viral meningitis by rapid multiplexed PCR assay12
The Human Papillomavirus (HPV) Laboratory e-Manual: A comprehensive guide for HPV testing and research12
The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis12
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series11
Clinical scoring system to predict viable viral shedding in patients with COVID-1911
Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan11
Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study)11
COVID-19 patient characteristics and time to viral clearance: A retrospective observational study in a multiethnic population (United Arab Emirates)11
Prevalence of human adenovirus in children with acute gastroenteritis in the New Vaccine Surveillance Network (NVSN) from 2016 to 201911
Arbovirus surveillance in pregnant women in north-central Nigeria, 2019–202211
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues11
Comparison of two new HTLV-I/II screening methods, Abbott Alinity i rHTLV-I/II and Diasorin LIAISON® XL murex recHTLV-I/II, to Abbott architect rHTLVI/II assay11
2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)11
Editorial Board11
A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-1910
TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion10
Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants10
Impact of metformin on HBV replication: No evidence of suppression in vitro10
Epstein-Barr virus (EBV) infection and its sequelae in the immunocompetent host10
Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-1910
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study10
Screening for cytomegalovirus shedding in vagina and saliva: Significant differences between biological fluids, swab types and storage durations in DNA recovery10
Molecular epidemiology of a Parainfluenza Type 3 virus outbreak: Informing infection control measures on adult hematology wards10
Coinfections and iterative detection of respiratory viruses among 17,689 patients between March 2021 and December 2022 in Southern France10
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays10
Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves10
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses10
Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis10
SpikeID: Rapid and unbiased identification of SARS-CoV-2 variants by spike sequencing10
SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests9
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study9
High rate of RNAemia and impaired immunity in patients with immunodeficiency in the vaccination era9
Performance of commercially available HIV in vitro diagnostic assays: A systematic review and meta-analysis9
Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loads9
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals9
Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy9
Cytomegalovirus urinary excretion in children with congenital and postnatally acquired infection9
Human papillomavirus incidence and transmission by vaccination status among heterosexual couples9
Clinical and molecular characteristics of the 2022 Enterovirus-D68 outbreak among hospitalized children, Ohio, USA9
Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France9
Epidemiologic, clinical, and genetic characteristics of influenza C virus infections among outpatients and inpatients in Sendai, Japan from 2006 to 20209
Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection9
Editorial Board9
Novel fully automated prototype assays for specific detection of phosphorylated and non-phosphorylated Hepatitis B core antigens9
Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay9
Virucidal activity of SARS-CoV-2 rapid antigen extraction buffers9
ESCV/PASCV Membership9
0.11373615264893